---
title: "Cadrenal Therapeutics, Inc. (CVKD.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CVKD.US.md"
symbol: "CVKD.US"
name: "Cadrenal Therapeutics, Inc."
industry: "Pharmaceuticals"
---

# Cadrenal Therapeutics, Inc. (CVKD.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [www.cadrenal.com](https://www.cadrenal.com) |

## Company Profile

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions. The company is developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in pa...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.90 | 99/257 | - | - | - |
| PB | 4.72 | 135/257 | 6.73 | 5.73 | 4.18 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-08T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 50% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 5.52 |
| Highest Target | 45.00 |
| Lowest Target | 30.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/CVKD.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CVKD.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CVKD.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.